Trial Profile
Planned phase II trial of IT-101 in patients with relapsed or refractory lymphoma.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2011
Price :
$35
*
At a glance
- Drugs Camptothecin (Primary)
- Indications B-cell lymphoma; Hodgkin's disease; T-cell lymphoma
- Focus Adverse reactions
- 18 Jun 2008 New trial record.